HDFC Life stock has garnered positive sentiment from major brokerages, with most maintaining a “buy” rating, while one remains cautious with a “neutral” stance. Here’s what the analysts are saying:
- Nuvama: Maintains a buy rating and raises the target price to ₹850 per share, reflecting confidence in the company’s growth potential.
- Investec: Reiterates a buy rating with a target price of ₹850 per share, aligning with Nuvama’s optimistic outlook.
- Jefferies: Holds a buy rating, setting the target price at ₹750 per share, emphasizing a positive long-term outlook.
- HSBC: Retains its buy rating with a target price of ₹750 per share, reflecting strong confidence in HDFC Life’s fundamentals.
- Antique: Maintains a buy rating, setting the target price at ₹810 per share, suggesting potential upside for the stock.
- Bernstein: Keeps an outperform rating with a target price of ₹810 per share, citing a robust performance trajectory.
- Macquarie: Maintains a neutral stance with a lower target price of ₹570 per share, highlighting cautious optimism and a more conservative approach compared to peers.
Most brokerages project a strong upside for HDFC Life stock, with target prices ranging from ₹750 to ₹850, while Macquarie remains on the sidelines with a neutral view.
Disclaimer: This report is for informational purposes only and should not be considered as financial advice. Please consult your financial advisor before making any investment decisions.
